AR103402A1 - Di-pidotimod benzatina y sus formas sólidas - Google Patents
Di-pidotimod benzatina y sus formas sólidasInfo
- Publication number
- AR103402A1 AR103402A1 ARP160100072A ARP160100072A AR103402A1 AR 103402 A1 AR103402 A1 AR 103402A1 AR P160100072 A ARP160100072 A AR P160100072A AR P160100072 A ARP160100072 A AR P160100072A AR 103402 A1 AR103402 A1 AR 103402A1
- Authority
- AR
- Argentina
- Prior art keywords
- pidotimod
- benzathine
- solid forms
- variables
- hydrate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente se refiere a di-pidotimod benzatina. En particular, se refiere a di-pidotimod benzatina en forma sólida tal como en cristalino o amorfa; también se describe polimorfos específicos tal como Forma M, Forma H y Forma H hidrato de di-pidotimod benzatina. En un aspecto adicional de la presente, se proporcionan los solvatos y cocristales de Forma H hidrato de di-pidotimod benzatina. En un aspecto adicional, se proporcionan variables solvatos de isopropanol; variables solvatos de etanol; variables hidratos; y un particular anhidrato. Las formas sólidas particulares incluyen solvatos de isopropanol variables de Forma J y Forma O de di-pidotimod benzatina; solvatos de etanol variables de Forma S y Forma W de di-pidotimod benzatina; hidratos variables de Forma X de di-pidotimod benzatina; y anhidrato de Forma T de di-pidotimod benzatina. En aspectos adicionales, se proporcionan procesos para obtener tales formas sólidas y métodos de tratar infecciones o enfermedades inflamatorias usando una o más de estas formas sólidas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/050635 WO2016112977A1 (en) | 2015-01-15 | 2015-01-15 | Di-pidotimod benzathine and solid forms thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR103402A1 true AR103402A1 (es) | 2017-05-10 |
Family
ID=52434751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100072A AR103402A1 (es) | 2015-01-15 | 2016-01-12 | Di-pidotimod benzatina y sus formas sólidas |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR103402A1 (es) |
| TW (1) | TW201636346A (es) |
| WO (2) | WO2016112977A1 (es) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1231723B (it) | 1989-08-11 | 1991-12-21 | Poli Ind Chimica Spa | Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmaceutiche che li contengono |
| IT1239029B (it) | 1989-10-12 | 1993-09-20 | Poli Ind Chimica Spa | Processo per la preparazione dell'acido 3-(l-piroglutamil)-l- tiazolidin-4-carbossilico e suoi derivati. |
| CN1680427B (zh) | 2005-02-01 | 2010-08-11 | 杨喜鸿 | 易于水溶解的匹多莫德复盐及其制备方法 |
| CN101423516A (zh) | 2008-01-16 | 2009-05-06 | 北京琥珀光华医药科技开发有限公司 | 匹多莫德钠的制备及其药用用途 |
| CN101411684A (zh) | 2008-12-03 | 2009-04-22 | 北京琥珀光华医药科技开发有限公司 | 一种含有匹多莫德钠的注射剂 |
| CN101766603A (zh) | 2008-12-26 | 2010-07-07 | 北京琥珀光华医药科技开发有限公司 | 一种增强免疫力的肌肉注射给药的注射液 |
| CN101768156A (zh) | 2008-12-26 | 2010-07-07 | 北京琥珀光华医药科技开发有限公司 | 匹多莫德精氨酸盐及其制剂 |
| CN101768157A (zh) | 2009-01-05 | 2010-07-07 | 梁艳杰 | 金刚烷胺匹多莫德羧酸盐及其制备方法和应用 |
| CN102100664A (zh) | 2009-12-16 | 2011-06-22 | 青岛康地恩药业有限公司 | 一种匹多莫德钾盐的注射剂及其制备方法 |
-
2015
- 2015-01-15 WO PCT/EP2015/050635 patent/WO2016112977A1/en active Application Filing
-
2016
- 2016-01-04 TW TW105100016A patent/TW201636346A/zh unknown
- 2016-01-12 WO PCT/EP2016/050439 patent/WO2016113242A1/en active Application Filing
- 2016-01-12 AR ARP160100072A patent/AR103402A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016113242A1 (en) | 2016-07-21 |
| TW201636346A (zh) | 2016-10-16 |
| WO2016112977A1 (en) | 2016-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017001617A1 (es) | Formas sólidas de un inhibidor ask1 referencia cruzada a aplicaciones relacionadas | |
| CO2017001884A2 (es) | Polimorfos de selinexor | |
| CL2017001289A1 (es) | Compuestos bicíclicos fusionados, sus composiciones y su uso para el tratamiento de enfermedades relacionadas con la modulación del receptor x farnesoide (fxr). | |
| CU24411B1 (es) | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos | |
| DK3699181T3 (da) | Krystallinsk form af (s)-n-(5-((r)-2-(2,5-difluorphenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamidhydrogensulfat | |
| CL2017001661A1 (es) | Compuestos biciclicos fusionados para el tratamiento de una enfermedad. | |
| WO2015195656A3 (en) | Synthesis of polycyclic-carbamoylpyridone compounds | |
| MA46972A (fr) | Forme polymorphe de sépiaptérine | |
| FR3039513B1 (fr) | Procede de fabrication additive d'un equipement aeronautique | |
| UY36287A (es) | COMPUESTO DE OBJETIVO A IL-23A y TNF-ALFA Y USO DEL MISMO | |
| CL2017001520A1 (es) | Supresión de iarn parental de genes de remodelación de cromatina para controlar plagas de coleópteros | |
| IT201600105178A1 (it) | Procedimento per la produzione di dieni | |
| IL266186A (en) | Process for the generation of thin silicon-containing films | |
| ES2874374T8 (es) | Proceso para producir hidrógeno | |
| IT201700028116A1 (it) | Gruppo di attuazione rotativo-lineare | |
| EP3138815A4 (en) | Process for producing potassium titanate | |
| DK3371126T3 (da) | Manipuleret hybrid cementbaseret sammensætning med øget modstandsdygtighed over for befugtning | |
| UY36169A (es) | Nuevas pirazolil-triazolil-piridinas como agentes plaguicidas | |
| EP3204469A4 (en) | Process for purification of organic composition | |
| BR112016019246A2 (pt) | processo paraa fabricação de hidroclorofluoro-olefinas | |
| MA40585A (fr) | Sel de dérivé de céphalosporine, forme solide cristalline de celui-ci et son procédé de production | |
| WO2015102024A3 (en) | Novel substituted 5 membered heterocyclic compounds and preparation thereof | |
| AR103402A1 (es) | Di-pidotimod benzatina y sus formas sólidas | |
| ITUA20161637A1 (it) | Metodo per la fabbricazione rapida di stampi | |
| ITUA20161550A1 (it) | Procedimento per la produzione di RNA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |